Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06866132 · ClinicalTrials.gov registry record · NA
Response to an Investigational Device in Patients With Restless Legs Syndrome
A NA study of Restless Legs Syndrome, sponsored by Noctrix Health.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06866132 is a NA study of Restless Legs Syndrome that is active but no longer recruiting, run by Noctrix Health. The registered enrollment target is 20 participants, below the 95-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06866132, a NA study of Restless Legs Syndrome, is active but no longer recruiting, sponsored by Noctrix Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Conditions Studied
Interventions
- DEVICE Investigational Noninvasive Neuromodulation Device
Study Locations (1)
California
- Noctrix Health Headquarters - Pleasanton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06866132
The ClinicalTrials.gov registry entry for NCT06866132 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (79% lower). The listed sponsor is Noctrix Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Restless Legs Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Investigational Noninvasive Neuromodulation Device is the first listed.
NCT06866132 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06866132 about?
NCT06866132 is a clinical study titled "Response to an Investigational Device in Patients With Restless Legs Syndrome". This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
What is the current status of trial NCT06866132?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-03-11. Estimated completion is 2025-09-30.
What conditions does trial NCT06866132 study?
This clinical trial studies the following conditions: Restless Legs Syndrome.
What interventions are being tested in trial NCT06866132?
The interventions under investigation include: Investigational Noninvasive Neuromodulation Device (DEVICE).
Who is sponsoring clinical trial NCT06866132?
This trial is sponsored by Noctrix Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06866132 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Restless Legs Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood Changes After Exercise in Restless Legs Syndrome
RECRUITING · NA
-
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction
COMPLETED · NA
-
A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
COMPLETED · NA
-
Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)
COMPLETED · NA
-
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
ACTIVE NOT RECRUITING · Phase 4
-
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.